logo
AI Icon𝛼SK or Search
ENTITY

PANACRO (Hangzhou) Pharmaceutical Consulting (PNCR HK)

2
Analysis
Health Care • Hong Kong
Panacro (Hangzhou) Pharmaceutical Consulting Co., Ltd. is a clinical Contract Research Organization (CRO) based in Hangzhou, China, dedicated to advancing clinical research through digital transformation. The company provides clinical trial technical services to accelerate the development and commercialization of chemical drugs and biologics for pharmaceutical and biotechnology companies in China and internationally.
more
bearish•PANACRO (Hangzhou) Pharmaceutical Consulting
•23 Aug 2026 11:01

PANACRO (Hangzhou) Pharmaceutical Consulting (PNCR HK): Synthetic Expert Call Transcript (23 Aug 2026)

PANACRO’s 38.9% gross profit margin in 2025 is an unsustainable structural outlier driven by revenue contraction and legacy vaccine trials,...

Logo
Share
bullish•PANACRO (Hangzhou) Pharmaceutical Consulting
•22 Aug 2026 10:16

IPO Databook: PANACRO (Hangzhou) Pharmaceutical Consulting (HK) - Aug 2026

Panacro (Hangzhou) Pharmaceutical Consulting Co., Ltd. is a clinical CRO based in Hangzhou, China, advancing clinical research through digital...

Logo
Share
No more insights

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x